内分泌耐药乳腺癌的新口服 SERD : 谁将受益最大 ?
Mesh : Humans Breast Neoplasms / drug therapy pathology genetics Female Drug Resistance, Neoplasm Antineoplastic Agents, Hormonal / therapeutic use Selective Estrogen Receptor Modulators / therapeutic use Administration, Oral
来 源: DOI:10.1016/j.annonc.2024.05.542